Ellis Investment Partners’s Cardinal Health CAH Stock Holding History

Ellis Investment Partners’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-122	Closed	-$8K	–	279
2022 Q3	$8K	Hold	122	–	–	﹤0.01%	595
2022 Q2	$6K	Hold	122	–	–	﹤0.01%	651
2022 Q1	$6K	Hold	122	–	–	﹤0.01%	671
2021 Q4	$6K	Hold	122	–	–	﹤0.01%	673
2021 Q3	$6K	Hold	122	–	–	﹤0.01%	657
2021 Q2	$6K	Hold	122	–	–	﹤0.01%	662
2021 Q1	$7K	Sell	122 -223	-65%	-$12.3K	﹤0.01%	613
2020 Q4	$18K	Buy	345 +3	+0.9%	+$156	0.01%	486
2020 Q3	$16K	Buy	342 +220	+180%	+$11.3K	0.01%	495
2020 Q2	$6K	Sell	122 -314	-72%	-$16.2K	﹤0.01%	591
2020 Q1	$20K	Buy	436 +3	+0.7%	+$156	0.01%	405
2019 Q4	$21K	Buy	433 +3	+0.7%	+$155	0.01%	431
2019 Q3	$20K	Buy	430 +102	+31%	+$4.66K	0.01%	441
2019 Q2	$15K	Buy	+328	New	+$15.1K	0.01%	475

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Ellis Investment Partners's CAH Position: Q4 2022 in Review

Ellis Investment Partners sold out of Cardinal Health (CAH) in Q4 2022, closing a stake of 122 shares — an estimated $8K sold.

Ellis Investment Partners first reported a position in CAH in Q2 2019 and held it in 14 quarters. The position peaked at $21K in Q4 2019. 929 funds tracked by Wall St. Rank hold CAH as of Q4 2022.

Ellis Investment Partners reported no remaining Cardinal Health position as of Q4 2022 after selling out during the quarter.
Ellis Investment Partners sold 122 Cardinal Health shares in Q4 2022, an estimated $8K.
Ellis Investment Partners first reported a position in Cardinal Health in Q2 2019 and held it in 14 quarters.
Ellis Investment Partners's Cardinal Health position peaked at $21K in Q4 2019.
929 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.